ABCA1 and metabolic syndrome: A study assessing the impact of 192 SNPs in HIV patients receiving antiretroviral therapy identified that the ABCA1 rs4149313 was associated with decreased TG and increased HDL-C circulating levels [256], while an independent study reported that ABCA1 rs2066714 was associated with a greater risk of dyslipidemia in patients under antiretroviral treatment [257].